In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $3.67 in the prior trading day, Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) closed at $3.52, down -4.09%. In other words, the price has decreased by -$4.09 from its previous closing price. On the day, 0.86 million shares were traded. IRWD stock price reached its highest trading level at $3.73 during the session, while it also had its lowest trading level at $3.44.
Ratios:
Our goal is to gain a better understanding of IRWD by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 6.12 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 4.36. For the most recent quarter (mrq), Quick Ratio is recorded 3.62 and its Current Ratio is at 3.62.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Leerink Partners on September 09, 2024, initiated with a Market Perform rating and assigned the stock a target price of $5.
On August 08, 2024, CapitalOne Downgraded its rating to Equal Weight which previously was Overweight and also lowered its target price recommendation from $12 to $4.
On January 17, 2024, Craig Hallum started tracking the stock assigning a Buy rating and target price of $21.Craig Hallum initiated its Buy rating on January 17, 2024, with a $21 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 18 ’24 when Davis Andrew sold 5,360 shares for $4.08 per share. The transaction valued at 21,869 led to the insider holds 284,685 shares of the business.
Emany Sravan Kumar sold 11,001 shares of IRWD for $44,884 on Nov 18 ’24. The SVP, COO and CFO now owns 309,572 shares after completing the transaction at $4.08 per share. On Nov 18 ’24, another insider, Davis Andrew, who serves as the Officer of the company, bought 6,090 shares for $4.11 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, IRWD now has a Market Capitalization of 587304960 and an Enterprise Value of 1089960960. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.43. Its current Enterprise Value per Revenue stands at 2.88 whereas that against EBITDA is 11.19.
Stock Price History:
Over the past 52 weeks, IRWD has reached a high of $15.70, while it has fallen to a 52-week low of $3.26. The 50-Day Moving Average of the stock is -14.74%, while the 200-Day Moving Average is calculated to be -45.37%.
Shares Statistics:
The stock has traded on average 1.61M shares per day over the past 3-months and 1751330 shares per day over the last 10 days, according to various share statistics. A total of 156.35M shares are outstanding, with a floating share count of 155.66M. Insiders hold about 2.73% of the company’s shares, while institutions hold 103.16% stake in the company. Shares short for IRWD as of 1731628800 were 8567112 with a Short Ratio of 5.32, compared to 1728950400 on 11931395. Therefore, it implies a Short% of Shares Outstanding of 8567112 and a Short% of Float of 10.35.
